Evidence map›Paper›PMID 26583155›Full record

ArticleJournal of immunology research2015

Prolactin and Dehydroepiandrosterone Levels in Women with Systemic Lupus Erythematosus: The Role of the Extrapituitary Prolactin Promoter Polymorphism at -1149G/T.

Edward L Treadwell, Kenneth Wiley, Beverly Word, William Melchior, William H Tolleson, Neera Gopee, George Hammons, Beverly D Lyn-Cook

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Androgen-Induced Immunosuppression.Frontiers in immunology · 2018
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Edward L TreadwellBrody School of Medicine, East Carolina University, Greenville, NC 27834, USA.
Kenneth WileyNational Human Genome Research Institute, Rockville, MD 20892, USA.
Beverly WordFDA-National Center for Toxicological Research, Jefferson, AR 72079, USA.
William MelchiorFDA-National Center for Toxicological Research, Jefferson, AR 72079, USA.
William H TollesonFDA-National Center for Toxicological Research, Jefferson, AR 72079, USA.
Neera GopeeFDA-National Center for Toxicological Research, Jefferson, AR 72079, USA.
George HammonsFDA-National Center for Toxicological Research, Jefferson, AR 72079, USA.
Beverly D Lyn-CookFDA-National Center for Toxicological Research, Jefferson, AR 72079, USA.
National Center for Toxicological Research · USEast Carolina University · USNational Human Genome Research Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) has shown an association with high levels of prolactin, low levels of dehydroepiandrosterone (DHEA), and induction of inflammatory cytokines in the serum of patients with the disease. This preliminary study examined the relevance of a -1149G/T functional single-nucleotide polymorphism (SNP) (rs1341239) in the promoter of the extrapituitary prolactin gene in a cohort of African American and European American women with lupus. Examination of this SNP revealed that the -1149TT genotype was correlated with higher levels of prolactin in serum and prolactin gene expression (p = 0.0001) in peripheral blood mononuclear cells (PBMCs). Lower levels of DHEA in serum were demonstrated in lupus patients (p = 0.001); those with the -1149TT genotype had the lowest levels of DHEA. Furthermore, a small subset of women who were on DHEA therapy and had a TT genotype showed a significant decrease in prolactin gene expression and lower disease activity scores (SLEDAI). Lupus patients, particularly African Americans, had significantly higher levels of IL-6 (p = 0.0001) and TNF-α (p = 0.042). This study suggests that the -1149TT genotype may be a risk factor for lupus and may predict who could possibly benefit from DHEA therapy; therefore, these results should be validated in a larger cohort with all ethnic groups.

Indexed as

Polymorphism, Single NucleotideAdultBlack or African AmericanDehydroepiandrosteroneFemaleGene ExpressionGene FrequencyGenetic Predisposition to DiseaseGenotypeHumansInterleukin-6Leukocytes, MononuclearLupus Erythematosus, SystemicMiddle AgedProlactinPromoter Regions, GeneticDehydroepiandrosteroneInterleukin-6ProlactinTumor Necrosis Factor-alpha

Identifiers

PMID26583155
PMCPMC4637102
OpenAlexW2163776977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.